Intersect ENT (XENT) Priced

Sells absorbable nasal implants for post-surgical sinusitis relief.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $13.20 0.00 (0.0%)
First Day Return 17.5%
Return from IPO 20.0%
 
Intersect ENT IPO News more
  • .
IPO Data
IPO File Date 06/23/2014
Offer Price $11.00
Price Range $11.00 - $13.00
Offer Shares (mm) 5.0
Deal Size ($mm) 55
 
IPO Data
IPO Date 07/23/2014
Offer Price $11.00
Price Range $11.00 - $13.00
Offer Shares (mm) 5.0
Deal Size ($mm) $55
 
Underwriters
more
Business Overview
Sells absorbable nasal implants for post-surgical sinusitis relief.
Sells absorbable nasal implants for post-surgical sinusitis relief.
more
Company Data
Headquarters Menlo Park, CA
Founded 2003
Employees 146
Website www.intersectent.com
 

Performance vs. IPO Index (IPOUSA)